Hyperfractionation: where do we stand?

This publication has 15 references indexed in Scilit:

• Hyperfractionation: where do we stand?
  Radiotherapy and Oncology, 1997
• Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
  Radiotherapy and Oncology, 1992
• Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Optimization of uncomplicated control for head and neck tumors
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Twice a day versus once a day radiation therapy in head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (Preliminary report) by the radiation therapy oncology group (RTOG)
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Benefit, risk, and optimization by roc analysis in cancer radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1985
• Maximum likelihood estimation of dose-response parameters for therapeutic operating characteristic (TOC) analysis of carcinoma of the nasopharynx
  International Journal of Radiation Oncology*Biology*Physics, 1982